Milestone Scientific, Inc. (MLSS) vs Nephros Inc. (NEPH)

Milestone Scientific, Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $45.0M against $37.2M — 1.2× the size. Milestone Scientific, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 27.2×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against 3.72%. Nephros Inc. has the higher net margin (8.38% vs −44.0%) and the higher return on invested capital (14.1% vs −136.2%). Across the 18 metrics below, Nephros Inc. leads on 17 and Milestone Scientific, Inc. on 1.

Valuation

Metric MLSS NEPH Medical Instruments & Supplies median
P/E n/m 27.15 34.17
P/S 4.05 2.22 2.83
P/B 11.00 3.84 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 23.83 16.08
EV/Sales 3.88 2.03 3.06
Earnings yield (10.73%) 3.68% (1.84%)
Free cash flow yield (2.24%) (1.71%) 0.17%

Profitability

Metric MLSS NEPH Medical Instruments & Supplies median
Gross margin 70.23% 61.26% 54.62%
Operating margin (43.56%) 7.92% 1.64%
Net margin (43.98%) 8.38% 0.00%
Free cash flow margin (6.98%) (3.19%) 1.61%
Return on equity (121.68%) 16.10% 0.00%
Return on assets (50.54%) 12.39% 0.00%
Return on invested capital (136.16%) 14.11% 0.00%

Growth

Metric MLSS NEPH Medical Instruments & Supplies median
Revenue growth (TTM) 3.72% 24.20% 9.20%
EPS growth (last fiscal year) (16.67%) 1,471.43% —
Revenue growth, 5-year CAGR 10.54% 17.02% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLSS NEPH Medical Instruments & Supplies median
Debt to equity 0.14 0.00 0.08
Current ratio 1.85 4.07 2.49
Net debt to EBITDA 0.05 (4.20) 0.83

Dividend

Metric MLSS NEPH Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric MLSS NEPH Medical Instruments & Supplies median
Market cap 37.23m 44.96m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack